Systematic review / meta-analysis / 2018
Adjunctive zinc therapy significantly reduced mortality from severe pneumonia in a meta-analysis of randomized controlled trials.
A meta-analysis of six randomized, double-blind, placebo-controlled trials involving 2,216 patients evaluated zinc as an adjunct therapy for severe pneumonia. Zinc produced a significant reduction in mortality caused by severe pneumonia (RR = 0.43, P = .01). However, it showed no significant improvement in treatment failure (RR = 0.97, P = .71), change of antibiotic therapy (RR = 1.09, P = .52), or clinical deterioration (RR = 0.88, P = .55).
- Study type
- Meta-analysis of randomized, double-blind, placebo-controlled trials
- Who was studied
- 2,216 patients with severe pneumonia across 6 trials
- What was measured
- Treatment failure, change of antibiotic therapy, clinical deterioration, and mortality
THE PAPER
Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials.
Wang L, Song Y. Clin Respir J, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.